Randomized trial of neoadjuvant vaccination with tumor-cell lysate induces T cell response in low-grade gliomas.

J Clin Invest · 2022 · PMC8803342 · PMID 34882581

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

borderline significanceP = 0.06so close (0.05 < p ≤ 0.1)

We observed the same trends when we selectively analyzed the data from oligodendroglioma patients, though the differences in IFN-γ or TNF-α concentration between screening and day of surgery time points in arm 1 patients only achieved borderline significance because of the smaller number of cases ( P = 0.06, Supplemental Figure 4B ).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.